These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24973312)

  • 1. Previous antibiotic exposure and antimicrobial resistance in invasive pneumococcal disease: results from prospective surveillance.
    Kuster SP; Rudnick W; Shigayeva A; Green K; Baqi M; Gold WL; Lovinsky R; Muller MP; Powis JE; Rau N; Simor AE; Walmsley SL; Low DE; McGeer A;
    Clin Infect Dis; 2014 Oct; 59(7):944-52. PubMed ID: 24973312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.
    Hicks LA; Chien YW; Taylor TH; Haber M; Klugman KP;
    Clin Infect Dis; 2011 Oct; 53(7):631-9. PubMed ID: 21890767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection.
    Resti M; Micheli A; Moriondo M; Becciolini L; Cortimiglia M; Canessa C; Indolfi G; Bartolini E; de Martino M; Azzari C
    Clin Ther; 2009 Jun; 31(6):1266-73. PubMed ID: 19695393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines.
    Hampton LM; Farley MM; Schaffner W; Thomas A; Reingold A; Harrison LH; Lynfield R; Bennett NM; Petit S; Gershman K; Baumbach J; Beall B; Jorgensen J; Glennen A; Zell ER; Moore M
    J Infect Dis; 2012 Feb; 205(3):401-11. PubMed ID: 22158567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
    Wierzbowski AK; Karlowsky JA; Adam HJ; Nichol KA; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2014 Jan; 69(1):59-66. PubMed ID: 23970485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000-2001).
    Oteo J; Campos J; Cruchaga S; Baquero G; Lázaro E; Madurga M; de Abajo FJ; Baquero F;
    Clin Microbiol Infect; 2004 Sep; 10(9):851-4. PubMed ID: 15355420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003.
    Adegbola RA; Hill PC; Secka O; Ikumapayi UN; Lahai G; Greenwood BM; Corrah T
    Trop Med Int Health; 2006 Jul; 11(7):1128-35. PubMed ID: 16827713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Australian Group on Antimicrobial Resistance (AGAR).
    Collignon PJ; Bell JM
    Med J Aust; 1996 Jan; 164(2):64-7. PubMed ID: 8569573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated antibiotic resistance and clinical spectrum of infections caused by Streptococcus pneumoniae in Taiwan: Emphasis on risk factors for penicillin nonsusceptibilities.
    Tsai HY; Lauderdale TL; Wang JT; Chen YS; Liu JW; Huang JH; Hu BH; Yang CJ; Lu DC; Chang SC
    J Microbiol Immunol Infect; 2013 Oct; 46(5):345-51. PubMed ID: 22992392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.
    Adam HJ; Hoban DJ; Gin AS; Zhanel GG
    Int J Antimicrob Agents; 2009 Jul; 34(1):82-5. PubMed ID: 19342204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
    Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
    Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations.
    Hackel M; Lascols C; Bouchillon S; Hilton B; Morgenstern D; Purdy J
    Vaccine; 2013 Oct; 31(42):4881-7. PubMed ID: 23928466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High proportion of nontypeable Streptococcus pneumoniae isolates among sporadic, nonoutbreak cases of bacterial conjunctivitis.
    Haas W; Hesje CK; Sanfilippo CM; Morris TW
    Curr Eye Res; 2011 Dec; 36(12):1078-85. PubMed ID: 21988450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
    Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.